Found: 94
Select item for more details and to access through your institution.
Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Hepatocellular adenoma among adult survivors of childhood and young adult cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Immune checkpoint inhibitors for hepatocellular carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Molecular profiling and analysis of genetic aberrations aimed at identifying potential therapeutic targets in fibrolamellar carcinoma of the liver.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Reconciling the prospect of disease progression with goals and expectations: Development and validation of a measurement model in advanced cancer.
- Published in:
- Psycho-Oncology, 2022, v. 31, n. 6, p. 902, doi. 10.1002/pon.5878
- By:
- Publication type:
- Article
SYSTEMIC THERAPIES FOR HEPATOCELLULAR CARCINOMA.
- Published in:
- Lebanese Medical Journal, 2010, v. 58, p. S28
- By:
- Publication type:
- Article
SYSTEMIC THERAPY AND NOVEL AGENTS IN THE TREATMENT OF PANCREAS CANCER.
- Published in:
- Lebanese Medical Journal, 2010, v. 58, p. S20
- By:
- Publication type:
- Article
TRIAGING AND CALL MANAGEMENT IN ONCOLOGY NURSING.
- Published in:
- Lebanese Medical Journal, 2010, v. 58, p. S66
- By:
- Publication type:
- Article
NURSING MANAGEMENT OF HAND-FOOT SYNDROME AND HAND-FOOT SKIN REACTION.
- Published in:
- Lebanese Medical Journal, 2010, v. 58, p. S63
- By:
- Publication type:
- Article
Predictive Biomarkers for Immune-Checkpoint Inhibitor Treatment Response in Patients with Hepatocellular Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 8, p. 7640, doi. 10.3390/ijms24087640
- By:
- Publication type:
- Article
Proportion of cancer in a Middle eastern country attributable to established risk factors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Recurrence of Hepatocellular Carcinoma After Complete Radiologic Response to Trans-Arterial Embolization: A Retrospective Study on Patterns, Treatments, and Prognoses.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 11, p. 6815, doi. 10.1245/s10434-022-12036-8
- By:
- Publication type:
- Article
Systemic Therapy for Hepatocellular Carcinoma: Cytotoxic Chemotherapy, Targeted Therapy and Immunotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2008, v. 15, n. 4, p. 1008, doi. 10.1245/s10434-007-9705-0
- By:
- Publication type:
- Article
Neo‐adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 6, p. 735, doi. 10.1111/ajco.13775
- By:
- Publication type:
- Article
MEK Inhibitor-Associated Ocular Hypertension.
- Published in:
- Ocular Oncology & Pathology, 2024, v. 10, n. 2, p. 98, doi. 10.1159/000535427
- By:
- Publication type:
- Article
The impact of new data in the treatment of advanced hepatocellular carcinoma.
- Published in:
- Current Oncology Reports, 2008, v. 10, n. 3, p. 199, doi. 10.1007/s11912-008-0031-x
- By:
- Publication type:
- Article
Pharmacokinetics/pharmacodynamics of ivosidenib in advanced IDH1-mutant cholangiocarcinoma: findings from the phase III ClarIDHy study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 5, p. 471, doi. 10.1007/s00280-023-04633-5
- By:
- Publication type:
- Article
Time‐to‐event modelling of effect of codrituzumab on overall survival in patients with hepatocellular carcinoma.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 944, doi. 10.1111/bcp.13530
- By:
- Publication type:
- Article
Non-Surgical Locoregional Therapies Alone or in Combination with Systemic Therapy in Patients with Hepatocellular Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1748, doi. 10.3390/cancers15061748
- By:
- Publication type:
- Article
Sustained Complete Response after Biological Downstaging in Patients with Hepatocellular Carcinoma: XXL-Like Prioritization for Liver Transplantation or "Wait and See" Strategy?
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2406, doi. 10.3390/cancers13102406
- By:
- Publication type:
- Article
Estrogen Receptor-α Suppresses Liver Carcinogenesis and Establishes Sex-Specific Gene Expression.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2355, doi. 10.3390/cancers13102355
- By:
- Publication type:
- Article
The Hepatic Innovation Team Collaborative: A Successful Population-Based Approach to Hepatocellular Carcinoma Surveillance.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2251, doi. 10.3390/cancers13092251
- By:
- Publication type:
- Article
Cancer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Autophagy-Associated Chemoresponse.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2134, doi. 10.3390/cancers13092134
- By:
- Publication type:
- Article
The Consumption of Cholesterol-Enriched Diets Conditions the Development of a Subtype of HCC with High Aggressiveness and Poor Prognosis.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1721, doi. 10.3390/cancers13071721
- By:
- Publication type:
- Article
Conversion Therapy of Intrahepatic Cholangiocarcinoma Is Associated with Improved Prognosis and Verified by a Case of Patient-Derived Organoid.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1179, doi. 10.3390/cancers13051179
- By:
- Publication type:
- Article
ASO Visual Abstract: Has Management of Intrahepatic Cholangiocarcinoma Evolved with the Evidence? Trends and Practice Patterns from the National Cancer Database.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Has Management of Intrahepatic Cholangiocarcinoma Evolved with the Evidence? Trends and Practice Patterns from the National Cancer Database.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 10, p. 6551, doi. 10.1245/s10434-024-15724-9
- By:
- Publication type:
- Article
Postoperative outcomes following pancreaticoduodenectomy: how should age affect clinical practice?
- Published in:
- World Journal of Surgical Oncology, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1477-7819-11-131
- By:
- Publication type:
- Article
Lymph-node ratio is an independent prognostic factor in patients with stage III colorectal cancer: a retrospective study from the Middle East.
- Published in:
- World Journal of Surgical Oncology, 2012, v. 10, n. 1, p. 63, doi. 10.1186/1477-7819-10-63
- By:
- Publication type:
- Article
PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 256, doi. 10.1159/000533650
- By:
- Publication type:
- Article
Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 72, doi. 10.1159/000527175
- By:
- Publication type:
- Article
First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 3, p. 268, doi. 10.1159/000522418
- By:
- Publication type:
- Article
Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 1, p. 38, doi. 10.1159/000519867
- By:
- Publication type:
- Article
Comparative Efficacy of Atezolizumab plus Bevacizumab and Other Treatment Options for Patients with Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 3, p. 240, doi. 10.1159/000515302
- By:
- Publication type:
- Article
Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 13978, doi. 10.1002/cam4.6033
- By:
- Publication type:
- Article
Low‐energy amplitude‐modulated electromagnetic field exposure: Feasibility study in patients with hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 11, p. 12402, doi. 10.1002/cam4.5944
- By:
- Publication type:
- Article
Mouse characteristics that affect establishing xenografts from hepatocellular carcinoma patient biopsies in the United States.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 3, p. 602, doi. 10.1002/cam4.4375
- By:
- Publication type:
- Article
Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 9, p. 3059, doi. 10.1002/cam4.3880
- By:
- Publication type:
- Article
Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 20, p. 7453, doi. 10.1002/cam4.3389
- By:
- Publication type:
- Article
Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor-Associated Retinopathy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Treatment options after sorafenib failure in patients with hepatocellular carcinoma.
- Published in:
- Clinical & Molecular Hepatology, 2017, v. 23, n. 4, p. 273, doi. 10.3350/cmh.2017.0108
- By:
- Publication type:
- Article
Expanding the treatment options for hepatocellular carcinoma: combining transarterial chemoembolization with radiofrequency ablation.
- Published in:
- 2008
- By:
- Publication type:
- commentary
Expanding the Treatment Options for Hepatocellular Carcinoma.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
Systemic Therapy for Advanced Hepatocellular Carcinoma in an Evolving Landscape.
- Published in:
- Current Treatment Options in Oncology, 2019, v. 20, n. 1, p. 1, doi. 10.1007/s11864-019-0601-1
- By:
- Publication type:
- Article
Advanced Hepatocellular Cancer: the Current State of Future Research.
- Published in:
- 2016
- By:
- Publication type:
- journal article
I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 0, doi. 10.1186/s13550-018-0374-8
- By:
- Publication type:
- Article
The Use of Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma.
- Published in:
- Gastroenterology & Hepatology, 2019, v. 15, n. 1, p. 48
- By:
- Publication type:
- Article
Brain Metastases in Pancreatic Ductal Adenocarcinoma: Assessment of Molecular Genotype-Phenotype Features-An Entity With an Increasing Incidence?
- Published in:
- 2018
- By:
- Publication type:
- journal article